Loading the security overview…
Where the tokens are
| Settlement | Shares short | Average daily volume | Days to cover |
|---|---|---|---|
| Sep 15, 2026 | 48.2K | 259.92K | 1.00 |
| Aug 31, 2026 | 119.85K | 265.62K | 1.00 |
| Aug 14, 2026 | 104.2K | 316.97K | 1.00 |
| Jul 31, 2026 | 177.54K | 466.3K | 1.00 |
| Jul 15, 2026 | 26.45K | 67.66K | 1.00 |
| Jun 30, 2026 | 1.51M | 376.25K | 4.02 |
| Jun 15, 2026 | 346.37K | 366.02K | 1.00 |
| May 29, 2026 | 417.77K | 461.63K | 1.00 |
| May 15, 2026 | 407.54K | 245.69K | 1.66 |
| Apr 30, 2026 | 534.22K | 473.45K | 1.13 |
| Apr 15, 2026 | 545.02K | 589.6K | 1.00 |
| Mar 31, 2026 | 535.11K | 1.21M | 1.00 |
The share of each day’s reported trading that was a short sale. This is not short interest: most of it is market makers selling short to fill buy orders and buying back within the day, so a ratio of 30–50% is ordinary for a heavily traded stock and says little about how many shares are held short overnight.
Figures describe Enlivex Therapeutics shares, not any token. As of Sep 15, 2026, from exchange short-interest reports and FINRA short-sale volume, via Massive. Short sellers borrow and sell the shares themselves; token holders are not lending theirs.